Cargando…

Epilepsy: Novel therapeutic targets

Despite of established and effective therapy for epilepsy, 20–25% patients develop therapeutic failure; this encourages finding newer drugs. Novel approaches target receptors which remain unaffected by conventional therapy or inhibit epileptogenesis. AMPA receptor antagonists have shown faster and c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anovadiya, Ashish P., Sanmukhani, Jayesh J., Tripathi, C. B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356950/ https://www.ncbi.nlm.nih.gov/pubmed/22629084 http://dx.doi.org/10.4103/0976-500X.95505

Ejemplares similares

Adverse drug reaction profile of oseltamivir in Indian population: A prospective observational study
por: Anovadiya, Ashish P., et al.
Publicado: (2011)

Phenytoin induced chorea in a pediatric patient: An interaction between phenytoin, phenobarbital and clobazam
por: Barvaliya, Manish, et al.
Publicado: (2011)

Ethics in Clinical Research: The Indian Perspective
por: Sanmukhani, J., et al.
Publicado: (2011)

Network science for the identification of novel therapeutic targets in epilepsy
por: Scott, Rod C.
Publicado: (2016)

Cross sensitivity between ciprofloxacin and levofloxacin for an immediate hypersensitivity reaction
por: Anovadiya, Ashish P., et al.
Publicado: (2011)

Ramosetron hydrochloride for the prevention of cancer chemotherapy induced nausea and vomiting: The Indian experience
por: Sanmukhani, Jayesh J., et al.
Publicado: (2014)

Effects of ethanolic extract of Jasminum grandiflorum Linn. flowers on wound healing in diabetic Wistar albino rats
por: Hirapara, Hiren, et al.
Publicado: (2017)

Novel astrocyte targets: New Avenues for the Therapeutic Treatment of Epilepsy
por: Crunelli, Vincenzo, et al.
Publicado: (2015)

Targeting the Ghrelin Receptor as a Novel Therapeutic Option for Epilepsy
por: Buckinx, An, et al.
Publicado: (2021)

Evaluation of wound healing activity of cow urine ark in diabetic Wistar albino rats
por: Hirapara, Hiren N., et al.
Publicado: (2016)

The CB(2) Receptor as a Novel Therapeutic Target for Epilepsy Treatment
por: Ji, Xiaoyu, et al.
Publicado: (2021)

Targeting ferroptosis as novel therapeutic approaches for epilepsy
por: Jin, Yuzi, et al.
Publicado: (2023)

Overview of Nrf2 as Therapeutic Target in Epilepsy
por: Carmona-Aparicio, Liliana, et al.
Publicado: (2015)

Insights into Potential Targets for Therapeutic Intervention in Epilepsy
por: Zavala-Tecuapetla, Cecilia, et al.
Publicado: (2020)

Transcription factors are potential therapeutic targets in epilepsy
por: Sun, Qihan, et al.
Publicado: (2022)

Intestinal Microbiota as an Alternative Therapeutic Target for Epilepsy
por: Wu, Jiaying, et al.
Publicado: (2016)

Fenofibrate Nanocrystals Embedded in Oral Strip-Films for Bioavailability Enhancement
por: Kevadiya, Bhavesh D., et al.
Publicado: (2018)

Preclinical evidence of ghrelin as a therapeutic target in epilepsy
por: Ge, Tongtong, et al.
Publicado: (2017)

Neuroinflammation in Post-Traumatic Epilepsy: Pathophysiology and Tractable Therapeutic Targets
por: Sharma, Rishabh, et al.
Publicado: (2019)

Recent treatment advances and novel therapeutic approaches in epilepsy
por: Serrano, Enrique, et al.
Publicado: (2015)

Targeting ferroptosis: A novel therapeutic strategy for the treatment of mitochondrial disease-related epilepsy
por: Kahn-Kirby, Amanda H., et al.
Publicado: (2019)

Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy children (6 months to 17 years of age): a randomized, multicenter, phase III clinical trial
por: Sarkar, Sumantra, et al.
Publicado: (2020)

Efficacy and Safety of Fluticasone Furoate and Oxymetazoline Nasal Spray: A Novel First Fixed Dose Combination for the Management of Allergic Rhinitis with Nasal Congestion
por: Kumar, R S, et al.
Publicado: (2022)

Metabolic Control of Epilepsy: A Promising Therapeutic Target for Epilepsy
por: Fei, Yanqing, et al.
Publicado: (2020)

Serotonin receptors in epilepsy: Novel treatment targets?
por: Sourbron, Jo, et al.
Publicado: (2022)

Non-Coding RNAs: New Biomarkers and Therapeutic Targets for Temporal Lobe Epilepsy
por: Manna, Ida, et al.
Publicado: (2022)

MicroRNAs in mouse and rat models of experimental epilepsy and potential therapeutic targets
por: Martinez, Bridget, et al.
Publicado: (2023)

Epilepsy surgery: Recommendations for India
por: Chandra, P. Sarat, et al.
Publicado: (2010)

Pharmacological and Therapeutic Approaches in the Treatment of Epilepsy
por: Ghosh, Shampa, et al.
Publicado: (2021)

Therapeutic Options for Childhood Absence Epilepsy
por: Rinaldi, Victoria Elisa, et al.
Publicado: (2021)

Integrated network analysis reveals potentially novel molecular mechanisms and therapeutic targets of refractory epilepsies
por: Chu, Hongwei, et al.
Publicado: (2017)

Tramadol-Induced Hiccups: A Report of Two Cases
por: Panchal, Radhika, et al.
Publicado: (2018)

The extratemporal lobe epilepsies in the epilepsy monitoring unit
por: Dash, Deepa, et al.
Publicado: (2014)

Novel Therapeutic Targets for Migraine
por: Nisar, Areeba, et al.
Publicado: (2023)

Extracellular Vesicles as Diagnostics and Therapeutics for Structural Epilepsies
por: Karttunen, Jenni, et al.
Publicado: (2019)

Montelukast: The New Therapeutic Option for the Treatment of Epilepsy
por: Tesfaye, Bekalu Amare, et al.
Publicado: (2021)

Pharmacological targeting of brain inflammation in epilepsy: Therapeutic perspectives from experimental and clinical studies
por: Ravizza, Teresa, et al.
Publicado: (2018)

Therapeutics of Epilepsy
por: Hamilton, Allan McLane
Publicado: (1876)

Novel therapeutic targets and agents for pediatric dyslipidemia
por: Sunil, Bhuvana, et al.
Publicado: (2021)

Temporally Targeted Interactions With Pathologic Oscillations as Therapeutical Targets in Epilepsy and Beyond
por: Földi, Tamás, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6rn6fa2ik95jvcvap0h4rq2t8g